{"name":"SUMITOMO PHARMA AM","slug":"sumitomo-pharma-am","ticker":"","exchange":"","domain":"sumitomopharmaam.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2013-01-01","label":"Aptiom first approved","drug":"Aptiom","drugSlug":"eslicarbazepine-acetate","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Eslicarbazepine Acetate first approved","drug":"Eslicarbazepine Acetate","drugSlug":"eslicarbazepine","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-01","label":"azoles Phase 3 readout (Anesthesia, Propofol Adverse Reaction)","drug":"azoles","drugSlug":"azoles","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"immunology","drugs":[{"name":"Formoterol 12 ųg BID","genericName":"Formoterol 12 ųg BID","slug":"formoterol-12-g-bid","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Salmeterol MDI","genericName":"Salmeterol MDI","slug":"salmeterol-mdi","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Arformoterol 25 ųg BID","genericName":"Arformoterol 25 ųg BID","slug":"arformoterol-25-g-bid","indication":"Chronic obstructive pulmonary disease (COPD) maintenance therapy","status":"phase_3"},{"name":"Arformoterol Tartrate Inhalation Solution","genericName":"Arformoterol Tartrate Inhalation Solution","slug":"arformoterol-tartrate-inhalation-solution","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"},{"name":"Levalbuterol HCl Inhalation Solution","genericName":"Levalbuterol HCl Inhalation Solution","slug":"levalbuterol-hcl-inhalation-solution","indication":"Acute bronchospasm in patients with reversible obstructive airway disease","status":"phase_3"},{"name":"Levalbuterol UDV TID","genericName":"Levalbuterol UDV TID","slug":"levalbuterol-udv-tid","indication":"Asthma maintenance and acute bronchospasm relief","status":"phase_3"},{"name":"Levalbuterol tartrate HFA MDI","genericName":"Levalbuterol tartrate HFA MDI","slug":"levalbuterol-tartrate-hfa-mdi","indication":"Acute bronchospasm in patients with reversible obstructive airway disease","status":"phase_3"},{"name":"Placebo plus Dexamethasone HFA","genericName":"Placebo plus Dexamethasone HFA","slug":"placebo-plus-dexamethasone-hfa","indication":"Asthma or chronic obstructive pulmonary disease (COPD) — Phase 3 trial indication likely respiratory inflammation","status":"phase_3"},{"name":"Racemic Albuterol","genericName":"Racemic Albuterol","slug":"racemic-albuterol","indication":"Acute bronchospasm relief in asthma","status":"phase_3"},{"name":"levalbuterol tartrate MDI","genericName":"levalbuterol tartrate MDI","slug":"levalbuterol-tartrate-mdi","indication":"Maintenance and relief of bronchospasm in asthma and in COPD","status":"phase_3"},{"name":"racemic albuterol MDI","genericName":"racemic albuterol MDI","slug":"racemic-albuterol-mdi","indication":"Acute bronchospasm relief in asthma","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"cardiovascular","drugs":[{"name":"AC-3933","genericName":"AC-3933","slug":"ac-3933","indication":"Other","status":"phase_2"},{"name":"Arformoterol and Tiotropium","genericName":"Arformoterol and Tiotropium","slug":"arformoterol-and-tiotropium","indication":"Other","status":"marketed"},{"name":"Eszopiclone (Lunesta)","genericName":"Eszopiclone (Lunesta)","slug":"eszopiclone-lunesta","indication":"Insomnia (sleep onset and sleep maintenance)","status":"marketed"},{"name":"Nusivertib","genericName":"Nusivertib","slug":"nusivertib","indication":"Other","status":"phase_1"},{"name":"azoles","genericName":"azoles","slug":"azoles","indication":"Other","status":"phase_1"},{"name":"ciclesonide nasal aerosol","genericName":"ciclesonide nasal aerosol","slug":"ciclesonide-nasal-aerosol","indication":"Allergic rhinitis","status":"marketed"},{"name":"mometasone nasal inhalation","genericName":"mometasone nasal inhalation","slug":"mometasone-nasal-inhalation","indication":"Allergic rhinitis","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"neuroscience","drugs":[{"name":"APL-130277","genericName":"APL-130277","slug":"apl-130277","indication":"Parkinson's disease, acute OFF episodes","status":"phase_3"},{"name":"Aptiom","genericName":"ESLICARBAZEPINE ACETATE","slug":"eslicarbazepine-acetate","indication":"Partial seizure","status":"marketed"},{"name":"Eslicarbazepine Acetate","genericName":"ESLICARBAZEPINE","slug":"eslicarbazepine","indication":"partial-onset seizures","status":"marketed"},{"name":"Lurasidone 20, 40, 60, 80 mg, flexibly dosed","genericName":"Lurasidone 20, 40, 60, 80 mg, flexibly dosed","slug":"lurasidone-20-40-60-80-mg-flexibly-dosed","indication":"Schizophrenia","status":"phase_3"},{"name":"Lurasidone HC1","genericName":"Lurasidone HC1","slug":"lurasidone-hc1","indication":"Schizophrenia","status":"phase_3"},{"name":"subcutaneous apomorphine","genericName":"subcutaneous apomorphine","slug":"subcutaneous-apomorphine","indication":"Acute motor fluctuations ('off' episodes) in advanced Parkinson's disease","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APO-go","genericName":"APO-go","slug":"apo-go","indication":"Treatment of iron deficiency anemia","status":"phase_2"}]}],"pipeline":[{"name":"APO-go","genericName":"APO-go","slug":"apo-go","phase":"phase_2","mechanism":"APO-go is a medication used to treat iron deficiency anemia.","indications":["Treatment of iron deficiency anemia"],"catalyst":""},{"name":"Formoterol 12 ųg BID","genericName":"Formoterol 12 ųg BID","slug":"formoterol-12-g-bid","phase":"phase_3","mechanism":"Formoterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Salmeterol MDI","genericName":"Salmeterol MDI","slug":"salmeterol-mdi","phase":"phase_3","mechanism":"Salmeterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"AC-3933","genericName":"AC-3933","slug":"ac-3933","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APL-130277","genericName":"APL-130277","slug":"apl-130277","phase":"phase_3","mechanism":"APL-130277 is a subcutaneous apomorphine formulation that acts as a dopamine agonist to provide rapid symptom relief in Parkinson's disease.","indications":["Parkinson's disease, acute OFF episodes"],"catalyst":""},{"name":"Aptiom","genericName":"ESLICARBAZEPINE ACETATE","slug":"eslicarbazepine-acetate","phase":"marketed","mechanism":"Aptiom works by blocking sodium channels in the brain to reduce the frequency of seizures.","indications":["Partial seizure"],"catalyst":""},{"name":"Arformoterol 25 ųg BID","genericName":"Arformoterol 25 ųg BID","slug":"arformoterol-25-g-bid","phase":"phase_3","mechanism":"Arformoterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance therapy","Asthma maintenance therapy"],"catalyst":""},{"name":"Arformoterol Tartrate Inhalation Solution","genericName":"Arformoterol Tartrate Inhalation Solution","slug":"arformoterol-tartrate-inhalation-solution","phase":"marketed","mechanism":"Arformoterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment"],"catalyst":""},{"name":"Arformoterol and Tiotropium","genericName":"Arformoterol and Tiotropium","slug":"arformoterol-and-tiotropium","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Eslicarbazepine Acetate","genericName":"ESLICARBAZEPINE","slug":"eslicarbazepine","phase":"marketed","mechanism":"Eslicarbazepine acetate works by stabilizing sodium channels in the brain, reducing the abnormal electrical activity that causes seizures.","indications":["partial-onset seizures"],"catalyst":""},{"name":"Eszopiclone (Lunesta)","genericName":"Eszopiclone (Lunesta)","slug":"eszopiclone-lunesta","phase":"marketed","mechanism":"Eszopiclone is a nonbenzodiazepine hypnotic that binds to GABA-A receptors in the brain to promote sleep onset and maintenance.","indications":["Insomnia (sleep onset and sleep maintenance)"],"catalyst":""},{"name":"Levalbuterol HCl Inhalation Solution","genericName":"Levalbuterol HCl Inhalation Solution","slug":"levalbuterol-hcl-inhalation-solution","phase":"phase_3","mechanism":"Levalbuterol is a selective beta-2 adrenergic receptor agonist that relaxes airway smooth muscle to improve breathing.","indications":["Acute bronchospasm in patients with reversible obstructive airway disease","Maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Levalbuterol UDV TID","genericName":"Levalbuterol UDV TID","slug":"levalbuterol-udv-tid","phase":"phase_3","mechanism":"Levalbuterol is a selective beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in patients with obstructive airway disease.","indications":["Asthma maintenance and acute bronchospasm relief","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Levalbuterol tartrate HFA MDI","genericName":"Levalbuterol tartrate HFA MDI","slug":"levalbuterol-tartrate-hfa-mdi","phase":"phase_3","mechanism":"Levalbuterol is a selective beta-2 adrenergic receptor agonist that relaxes airway smooth muscle to improve breathing.","indications":["Acute bronchospasm in patients with reversible obstructive airway disease","Maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Lurasidone 20, 40, 60, 80 mg, flexibly dosed","genericName":"Lurasidone 20, 40, 60, 80 mg, flexibly dosed","slug":"lurasidone-20-40-60-80-mg-flexibly-dosed","phase":"phase_3","mechanism":"Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors in the brain.","indications":["Schizophrenia","Bipolar I disorder depression"],"catalyst":""},{"name":"Lurasidone HC1","genericName":"Lurasidone HC1","slug":"lurasidone-hc1","phase":"phase_3","mechanism":"Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors in the brain.","indications":["Schizophrenia","Bipolar I disorder depression","Major depressive disorder (adjunctive treatment)"],"catalyst":""},{"name":"Nusivertib","genericName":"Nusivertib","slug":"nusivertib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo plus Dexamethasone HFA","genericName":"Placebo plus Dexamethasone HFA","slug":"placebo-plus-dexamethasone-hfa","phase":"phase_3","mechanism":"Dexamethasone is a corticosteroid that suppresses immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Asthma or chronic obstructive pulmonary disease (COPD) — Phase 3 trial indication likely respiratory inflammation"],"catalyst":""},{"name":"Racemic Albuterol","genericName":"Racemic Albuterol","slug":"racemic-albuterol","phase":"phase_3","mechanism":"Racemic albuterol is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing.","indications":["Acute bronchospasm relief in asthma","Acute bronchospasm relief in chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"azoles","genericName":"azoles","slug":"azoles","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ciclesonide nasal aerosol","genericName":"ciclesonide nasal aerosol","slug":"ciclesonide-nasal-aerosol","phase":"marketed","mechanism":"Ciclesonide is an inhaled corticosteroid that reduces inflammation in the nasal airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production.","indications":["Allergic rhinitis","Nasal polyps (in some formulations/regions)"],"catalyst":""},{"name":"levalbuterol tartrate MDI","genericName":"levalbuterol tartrate MDI","slug":"levalbuterol-tartrate-mdi","phase":"phase_3","mechanism":"Levalbuterol tartrate is a long-acting beta2-adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.","indications":["Maintenance and relief of bronchospasm in asthma and in COPD"],"catalyst":""},{"name":"mometasone nasal inhalation","genericName":"mometasone nasal inhalation","slug":"mometasone-nasal-inhalation","phase":"phase_3","mechanism":"Mometasone is a corticosteroid that works by inhibiting the release of pro-inflammatory cytokines and mediators.","indications":["Allergic rhinitis","Chronic rhinitis"],"catalyst":""},{"name":"racemic albuterol MDI","genericName":"racemic albuterol MDI","slug":"racemic-albuterol-mdi","phase":"phase_3","mechanism":"Racemic albuterol is a beta-2 adrenergic agonist that relaxes airway smooth muscle to relieve bronchospasm and improve airflow in obstructive airway diseases.","indications":["Acute bronchospasm relief in asthma","Chronic obstructive pulmonary disease (COPD) maintenance and acute symptom relief"],"catalyst":""},{"name":"subcutaneous apomorphine","genericName":"subcutaneous apomorphine","slug":"subcutaneous-apomorphine","phase":"phase_3","mechanism":"Subcutaneous apomorphine is a dopamine agonist that stimulates dopamine receptors in the brain to rapidly relieve motor symptoms of Parkinson's disease.","indications":["Acute motor fluctuations ('off' episodes) in advanced Parkinson's disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":25,"phaseCounts":{"phase_2":2,"phase_3":15,"marketed":6,"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}